Beijing Wantai Biological Pharmacy Enterprise Co.,Ltd.’s Net Profit Rose 281.7% in First Half of 2022

Beijing Wantai Biological Pharmacy Enterprise Co.,Ltd. (北京万泰生物药业股份有限公司) (603392.SH) reported a net profit of 2.8 billion yuan in the first half of 2022, up 281.7% year-on-year.

Meanwhile, the company posted 5.9 billion yuan in revenue, up 201.9% year-on-year.

At the end of the reporting period, it had 14 billion yuan in total assets and 3.4 billion yuan in total liabilities, with a liability-to-asset ratio of 24%.